Follow
Simon Hutter
Title
Cited by
Cited by
Year
Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules
MK Vormann, L Gijzen, S Hutter, L Boot, A Nicolas, A van den Heuvel, ...
The AAPS journal 20, 1-11, 2018
1182018
Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies
MK Vormann, J Vriend, HL Lanz, L Gijzen, A van den Heuvel, S Hutter, ...
Journal of Pharmaceutical Sciences 110 (4), 1601-1614, 2021
672021
Combining extracellular miRNA determination with microfluidic 3D cell cultures for the assessment of nephrotoxicity: a proof of concept study
L Suter-Dick, L Mauch, D Ramp, M Caj, MK Vormann, S Hutter, HL Lanz, ...
The AAPS journal 20, 1-9, 2018
382018
Anti-inflammatory activity of cyanobacterial serine protease inhibitors aeruginosin 828A and cyanopeptolin 1020 in human hepatoma cell line Huh7 and effects in Zebrafish (Danio …
S Faltermann, S Hutter, V Christen, T Hettich, K Fent
Toxins 8 (7), 219, 2016
172016
Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH
A Kermanizadeh, J Valli, K Sanchez, S Hutter, A Pawlowska, G Whyte, ...
Archives of toxicology, 1-17, 2022
82022
Combined investigation of anti-tumor efficacy and liver safety of bispecific T cell engagers in immune-competent high-throughput co-culturing platform
M Rudnik, OY Grining, S Hutter, F Greve, DO Franyuti, R Matheis, ...
Cancer Research 83 (7_Supplement), 2747-2747, 2023
12023
New microplate platform with cryopreserved 3D tumor spheroids for faster and convenient pre-clinical testing
N Goedecke, S Stroebel, S Hutter, T Issa, I Agarkova, LA Ligeon, O Frey
Cancer Research 84 (6_Supplement), 6778-6778, 2024
2024
Recapitulating insulin resistance in a 3D human liver model for efficacy testing of drug candidates
L Hoelting, S Hutter, A Menghini, A Zehnder, W Moritz, R Kostadinova, ...
Insulin [nM] 8, 16, 2022
2022
Recapitulating insulin resistance in a 3D human liver model for efficacy testing of drug candidates
R Kostadinova, L Hoelting, S Hutter, A Menghini, A Zehnder, W Moritz, ...
Journal of Hepatology 77, S703, 2022
2022
3D Nephroscreen: high throughput drug-induced nephrotoxicity screening on a microfluidic proximal tubule model
L GIJZEN, MK VORMANN, S HUTTER, J VRIEND, A vd HEUVEL, ...
日本毒性学会学術年会 第 49 回日本毒性学会学術年会, P-164, 2022
2022
Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies
L Suter-Dick, M Caj, S Hutter, M Vormann, J Vriend, H Lanz, L Gijzen, ...
Elsevier, 2021
2021
3D Nephroscreen: high throughput drug-induced nephrotoxicity screening on a microfluidic proximal tubule model
L GIJZEN, MK VORMANN, S HUTTER, J VRIEND, A vd HEUVEL, ...
日本毒性学会学術年会 第 48 回日本毒性学会学術年会, O-30, 2021
2021
3D NephroScreen: high throughput drug-induced nephrotoxicity screening on a proximal tubule-on-a-chip model
L Gijzen, MK Vormann, S Hutter, J Vriend, SJ Trietsch, J Joore, M Wilmer, ...
Toxicology Letters 295, S68, 2018
2018
Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study
L Mauch, MK Vormann, S Hutter, H Lanz, M Wilmer, D Ramp, ...
2018
The system can't perform the operation now. Try again later.
Articles 1–14